BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36208391)

  • 1. Investigation of the Efficacy and Safety of 650 nm Low-Level Red Light for Myopia Control in Children: A Randomized Controlled Trial.
    Tian L; Cao K; Ma DL; Zhao SQ; Lu LX; Li A; Chen CX; Ma CR; Ma ZF; Jie Y
    Ophthalmol Ther; 2022 Dec; 11(6):2259-2270. PubMed ID: 36208391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily Low-Level Red Light for Spherical Equivalent Error and Axial Length in Children With Myopia: A Randomized Clinical Trial.
    Cao K; Tian L; Ma DL; Zhao SQ; Li A; Jin ZB; Jie Y
    JAMA Ophthalmol; 2024 Jun; 142(6):560-567. PubMed ID: 38662345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month repeated irradiation of 650 nm low-level red light reduces the risk of myopia in children: a randomized controlled trial.
    Tian L; Cao K; Ma DL; Lu LX; Zhao SQ; Li A; Chen CX; Ma ZF; Jin ZB; Ma CR; Jie Y
    Int Ophthalmol; 2023 Oct; 43(10):3549-3558. PubMed ID: 37318667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-level red-light therapy for myopia control in children: A systematic review and meta-analysis.
    Amaral DC; Batista S; Dos Santos-Neto E; Manso JEF; Rodrigues MPM; Monteiro MLR; Alves MR; Louzada RN
    Clinics (Sao Paulo); 2024; 79():100375. PubMed ID: 38723579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial.
    Jiang Y; Zhu Z; Tan X; Kong X; Zhong H; Zhang J; Xiong R; Yuan Y; Zeng J; Morgan IG; He M
    Ophthalmology; 2022 May; 129(5):509-519. PubMed ID: 34863776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated Low-Level Red-Light Therapy for Myopia Control in High Myopia Children and Adolescents: A Randomized Clinical Trial.
    Xu Y; Cui L; Kong M; Li Q; Feng X; Feng K; Zhu H; Cui H; Shi C; Zhang J; Zou H
    Ophthalmology; 2024 Jun; ():. PubMed ID: 38849054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children: A Randomized, Double-Blind, Controlled Clinical Trial.
    Dong J; Zhu Z; Xu H; He M
    Ophthalmology; 2023 Feb; 130(2):198-204. PubMed ID: 36049646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy Comparison of Repeated Low-Level Red Light and Low-Dose Atropine for Myopia Control: A Randomized Controlled Trial.
    Chen Y; Xiong R; Chen X; Zhang J; Bulloch G; Lin X; Wu X; Li J
    Transl Vis Sci Technol; 2022 Oct; 11(10):33. PubMed ID: 36269184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-intensity, long-wavelength red light slows the progression of myopia in children: an Eastern China-based cohort.
    Zhou L; Xing C; Qiang W; Hua C; Tong L
    Ophthalmic Physiol Opt; 2022 Mar; 42(2):335-344. PubMed ID: 34981548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Different Powers of Low-Level Red Light in Children for Myopia Control.
    Zhou W; Liao Y; Wang W; Sun Y; Li Q; Liu S; Tang J; Li L; Wang X
    Ophthalmology; 2024 Jan; 131(1):48-57. PubMed ID: 37634757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red light instruments for myopia exceed safety limits.
    Ostrin LA; Schill AW
    Ophthalmic Physiol Opt; 2024 Mar; 44(2):241-248. PubMed ID: 38180093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence.
    Zhou L; Tong L; Li Y; Williams BT; Qiu K
    Sci Rep; 2023 Feb; 13(1):3321. PubMed ID: 36849626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to slow progression of myopia in children.
    Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Repeated Low-Level Red Light (RLRL) therapy on myopia outcomes in children: a systematic review and meta-analysis.
    Youssef MA; Shehata AR; Adly AM; Ahmed MR; Abo-Bakr HF; Fawzy RM; Gouda AT
    BMC Ophthalmol; 2024 Feb; 24(1):78. PubMed ID: 38378527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial.
    Bao J; Huang Y; Li X; Yang A; Zhou F; Wu J; Wang C; Li Y; Lim EW; Spiegel DP; Drobe B; Chen H
    JAMA Ophthalmol; 2022 May; 140(5):472-478. PubMed ID: 35357402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study): A Randomized Clinical Trial.
    Prousali E; Haidich AB; Dastiridou A; Tzamalis A; Ziakas N; Mataftsi A
    Cureus; 2022 Jun; 14(6):e25995. PubMed ID: 35720776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
    Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Center-for-Near Extended-Depth-of-Focus Soft Contact Lens for Myopia Control in Children: 1-Year Results of a Randomized Controlled Trial.
    Shen EP; Chu HS; Cheng HC; Tsai TH
    Ophthalmol Ther; 2022 Aug; 11(4):1577-1588. PubMed ID: 35737291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
    JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of spectacle lenses designed to reduce relative peripheral hyperopia on myopia progression in Japanese children: a 2-year multicenter randomized controlled trial.
    Kanda H; Oshika T; Hiraoka T; Hasebe S; Ohno-Matsui K; Ishiko S; Hieda O; Torii H; Varnas SR; Fujikado T
    Jpn J Ophthalmol; 2018 Sep; 62(5):537-543. PubMed ID: 30083910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.